News

Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity
A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...
Scientific Research Publishing35m
Identification and Assessment of Regulatory Challenges in VLFS Projects with Ammonia Production ()
Therefore, this report aims to outline the identification and assessment of regulatory challenges in VLFS Projects with ...